SEC Form 4 · accession 0001179110-15-000807

GILEAD SCIENCES, INC. · GILD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP Commercial Ops

Period of report

Jan 8, 2015

Accepted (ET)

Jan 12, 2015 · 3:55 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000882095

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 8, 2015	M	717	$40.56	A	35,025	D
Common Stock	Jan 8, 2015	M	283	$26.99	A	35,308	D
Common Stock^F4	Jan 8, 2015	S	1,000	$100.8805	D	34,308	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F3	$26.99	Jan 8, 2015	M	283	D	—	Jul 30, 2018	Common Stock	283	23,981	D
Non-Qualified Stock Option (right to buy)^F2	$40.56	Jan 8, 2015	M	717	D	—	Feb 1, 2023	Common Stock	717	17,523	D

F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F4Sale prices reported for the transactions reported here range from $100.88 to $100.89. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.